^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    FXYD3 expression

    i
    Other names: FXYD3, FXYD Domain Containing Ion Transport Regulator 3, FXYD Domain-Containing Ion Transport Regulator 3, PLML, Sodium/Potassium-Transporting ATPase Subunit FXYD3, Chloride Conductance Inducer Protein Mat-8, Mammary Tumor 8 KDa Protein, MAT-8, MAT8, Phospholemman-Like Protein, Phospholemman-Like
    Entrez ID:
    5349
    1year
    FXYD3 Is Frequently Expressed in Pancreatic Ductal Adenocarcinoma but Does Not Predict Survival. (PubMed, Cancer Med)
    Immunohistochemical FXYD3 expression does not predict survival in chemo-naive PDAC patients, but is associated with late-stage disease. The high rate of FXYD3 overexpression warrants therapeutic evaluation.
    Journal
    |
    FXYD3 (FXYD Domain Containing Ion Transport Regulator 3)
    |
    FXYD3 expression
    over1year
    Uncovering the role of FXYD3 as a potential oncogene and early biomarker in pancreatic cancer. (PubMed, Am J Cancer Res)
    Thus, in the follow-up study, we will demonstrate the functional role of FXYD3 in pancreatic cancer tumorigenesis. This study revealed that the FXYD3 may act as a significant oncogene in the early stage of pancreatic cancer.
    Journal
    |
    FXYD3 (FXYD Domain Containing Ion Transport Regulator 3) • B3GNT3 (UDP-GlcNAc:BetaGal Beta-1,3-N-Acetylglucosaminyltransferase 3)
    |
    FXYD3 expression